Science Communication
Dr. Nazish Jeffery is a Bioeconomy Policy Manager with the Federation of American Scientists focused on developing tools in order to advance US biotech and measure the US bioeconomy. Prior to joining FAS, Nazish was a process development scientist in the biotech industry in Boston, MA.
Nazish graduated from the University of Rochester School of Medicine with her PhD in biochemistry and molecular Biology. During her time in graduate school, Nazish founded the Science Policy Initiative to promote science policy at the graduate level. In addition, she has previously volunteered with FAS to promote STEM funding and has also interned at the American Institute of Biological Sciences working specifically on how to improve and advance the US bioeconomy. Nazish has extensive experience in communicating science to a variety of stakeholders, and developing recommendations to advance the US STEM initiative.
By providing essential funding mechanisms, the Bioeconomy Finance Program will reduce the risks inherent in biotechnology innovation, encouraging more private sector investment.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
To understand the range of governmental priorities for the bioeconomy, we spoke with key agencies represented on the National Bioeconomy Board to collect their perspectives.
We sat down with Congressman Jake Auchincloss to get a better understanding of how Congress and the Select Committee on the CCP view the need for standards for the bioeconomy.
In the quest for sustainable energy and materials, biomass emerges as a key player, bridging the gap between the energy sector and the burgeoning U.S. and regional bioeconomies.
Multiple bioeconomy-related programs were authorized through the bipartisan CHIPS & Science legislation but have yet to receive anywhere near their funding targets.
While the U.S. government grapples with the definition of the bioeconomy and what sectors it does and does not contain, another definitional issue needs to be addressed: What does sustainability mean in a bioeconomy?
We’ve created a living table to track progress on the Bioeconomy EO, enhance accountability, and follow the state of the U.S. bio economy as it evolves.
The landscape of biosecurity risks related to AI is complex and rapidly changing, and understanding the range of issues requires diverse perspectives and expertise. Here are five promising ideas that match the diversity of challenges that AI poses in the life sciences.
September should be bioeconomy month. To celebrate, we took our experts to the Hill to share their research and recommendations with Congress.
We sat down with MicroByre CEO Dr. Sarah Richardson to talk about biomanufacturing, corn sugar’s pitfalls, and more.
To develop an overarching framework that includes addressing bio-related risks, Congress, federal agencies, and non-governmental AI stakeholders must work together.